HTRS Hosts Webinar: Novel Therapies In VWD And Rare Bleeding Disorders
Hemostasis & Thrombosis Research Society (HTRS) posted on LinkedIn:
”Join HTRS for our upcoming educational webinar: “Novel Therapies in VWD and Rare Bleeding Disorders” on Tuesday, October 21 at 3:00PM EST.
Discover the latest advances in treatment and research for von Willebrand disease (VWD) and rare bleeding disorders with two renowned experts:
Dr. Debbie Jiang – Adult classical hematologist at Massachusetts General Hospital and the Boston Bleeding Disorders Center. A recipient of the HTRS/Novo Nordisk Clinical Scholar Award, Dr. Jiang is dedicated to advancing care and research for bleeding and clotting disorders.
Dr. Stacy Croteau – Pediatric hematologist and clinical researcher at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. As Medical Director of the Boston Bleeding Disorders Center and National Chair of the ATHN/NHPCC Transition Working Group, Dr. Croteau leads efforts to improve outcomes and transitions of care for individuals with bleeding disorders.
Don’t miss this opportunity to hear directly from leaders shaping the future of bleeding disorder care. Register now to secure your spot.”
Stay updated with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines